Literature DB >> 31557548

Multi-outcome meta-analysis (MOMA) of cognitive remediation in schizophrenia: Revisiting the relevance of human coaching and elucidating interplay between multiple outcomes.

Lana Kambeitz-Ilankovic1, Linda T Betz2, Clara Dominke2, Shalaila S Haas3, Karuna Subramaniam4, Melisa Fisher5, Sophia Vinogradov5, Nikolaos Koutsouleris6, Joseph Kambeitz2.   

Abstract

Cognitive remediation (CR) is nowadays mainly administered in a computerized fashion, yet frequently supplemented by human guidance. The effects of CR on cognitive, functional and clinical outcomes are consistently reported, yet the response is heterogeneous. In order to resolve this heterogeneity, we employed a multi-outcome meta-analytic approach, examined effects of CR on each outcome category separately and estimated directed effects between three outcome categories. We extracted treatment effects from 67 studies that trained patients with schizophrenia (total n = 4067) using either 1) computerized CR modality alone or 2) in combination with supplementary human guidance (SHG). All three outcome domains were significantly improved by CR with small to moderate effect sizes when assessing outcomes across all studies. The comparison between CR administered with SHG revealed largest effects on the cognitive subdomains of working and verbal memory. Structural equation modeling in the single-study data suggests that cognitive gains trigger restoration of psychosocial functioning which in turn facilitates improvement in clinical symptoms.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31557548      PMCID: PMC8942567          DOI: 10.1016/j.neubiorev.2019.09.031

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  55 in total

1.  Second-generation antipsychotic effect on cognition in patients with schizophrenia--a meta-analysis of randomized clinical trials.

Authors:  R E Nielsen; S Levander; G Kjaersdam Telléus; S O W Jensen; T Østergaard Christensen; S Leucht
Journal:  Acta Psychiatr Scand       Date:  2015-01-16       Impact factor: 6.392

2.  The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study.

Authors:  Eric C Meyer; Ricardo E Carrión; Barbara A Cornblatt; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Elaine F Walker; Scott W Woods; Robert Heinssen; Larry J Seidman
Journal:  Schizophr Bull       Date:  2014-02-18       Impact factor: 9.306

3.  Neurocognition and occupational functioning in patients with first-episode psychosis: a 2-year follow-up study.

Authors:  Marte Tandberg; Torill Ueland; Kjetil Sundet; Ulrik Haahr; Inge Joa; Jan Olav Johannessen; Tor Ketil Larsen; Stein Opjordsmoen; Bjørn Rishovd Rund; Jan Ivar Røssberg; Erik Simonsen; Per Vaglum; Ingrid Melle; Svein Friis; Thomas McGlashan
Journal:  Psychiatry Res       Date:  2011-05-14       Impact factor: 3.222

4.  The positive and negative syndrome scale (PANSS) for schizophrenia.

Authors:  S R Kay; A Fiszbein; L A Opler
Journal:  Schizophr Bull       Date:  1987       Impact factor: 9.306

Review 5.  Identification of separable cognitive factors in schizophrenia.

Authors:  Keith H Nuechterlein; Deanna M Barch; James M Gold; Terry E Goldberg; Michael F Green; Robert K Heaton
Journal:  Schizophr Res       Date:  2004-12-15       Impact factor: 4.939

6.  A Multicenter, Rater-Blinded, Randomized Controlled Study of Auditory Processing-Focused Cognitive Remediation Combined With Open-Label Lurasidone in Patients With Schizophrenia and Schizoaffective Disorder.

Authors:  Joshua T Kantrowitz; Zafar Sharif; Alice Medalia; Richard S E Keefe; Philip Harvey; Gerard Bruder; Deanna M Barch; Tse Choo; Seonjoo Lee; Jeffrey A Lieberman
Journal:  J Clin Psychiatry       Date:  2016-06       Impact factor: 4.384

Review 7.  A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book.

Authors:  Aaron L Mishara; Terry E Goldberg
Journal:  Biol Psychiatry       Date:  2004-05-15       Impact factor: 13.382

Review 8.  The Quality of Life Scale (QOLS): reliability, validity, and utilization.

Authors:  Carol S Burckhardt; Kathryn L Anderson
Journal:  Health Qual Life Outcomes       Date:  2003-10-23       Impact factor: 3.186

9.  A new generation computerised metacognitive cognitive remediation programme for schizophrenia (CIRCuiTS): a randomised controlled trial.

Authors:  C Reeder; V Huddy; M Cella; R Taylor; K Greenwood; S Landau; T Wykes
Journal:  Psychol Med       Date:  2017-09-04       Impact factor: 7.723

10.  Efficacy of different types of cognitive enhancers for patients with schizophrenia: a meta-analysis.

Authors:  Igne Sinkeviciute; Marieke Begemann; Merel Prikken; Bob Oranje; Erik Johnsen; Wan U Lei; Kenneth Hugdahl; Rune A Kroken; Carina Rau; Jolien D Jacobs; Silvia Mattaroccia; Iris E Sommer
Journal:  NPJ Schizophr       Date:  2018-10-25
View more
  21 in total

1.  Efficacy and acceptability of psychosocial interventions in schizophrenia: systematic overview and quality appraisal of the meta-analytic evidence.

Authors:  Marco Solmi; Giovanni Croatto; Giada Piva; Stella Rosson; Paolo Fusar-Poli; Jose M Rubio; Andre F Carvalho; Eduard Vieta; Celso Arango; Nicole R DeTore; Elizabeth S Eberlin; Kim T Mueser; Christoph U Correll
Journal:  Mol Psychiatry       Date:  2022-08-23       Impact factor: 13.437

2.  European Psychiatric Association guidance on assessment of cognitive impairment in schizophrenia.

Authors:  Antonio Vita; Wolfgang Gaebel; Armida Mucci; Gabriele Sachs; Andreas Erfurth; Stefano Barlati; Federico Zanca; Giulia Maria Giordano; Louise Birkedal Glenthøj; Merete Nordentoft; Silvana Galderisi
Journal:  Eur Psychiatry       Date:  2022-09-05       Impact factor: 7.156

Review 3.  European Psychiatric Association guidance on treatment of cognitive impairment in schizophrenia.

Authors:  Antonio Vita; Wolfgang Gaebel; Armida Mucci; Gabriele Sachs; Stefano Barlati; Giulia Maria Giordano; Gabriele Nibbio; Merete Nordentoft; Til Wykes; Silvana Galderisi
Journal:  Eur Psychiatry       Date:  2022-09-05       Impact factor: 7.156

4.  A subtype of institutionalized patients with schizophrenia characterized by pronounced subcortical and cognitive deficits.

Authors:  Qiannan Zhao; Hengyi Cao; Wenjing Zhang; Siyi Li; Yuan Xiao; Carol A Tamminga; Matcheri S Keshavan; Godfrey D Pearlson; Brett A Clementz; Elliot S Gershon; Scot Kristian Hill; Sarah K Keedy; Elena I Ivleva; Rebekka Lencer; John A Sweeney; Qiyong Gong; Su Lui
Journal:  Neuropsychopharmacology       Date:  2022-03-08       Impact factor: 8.294

5.  A Meta-analysis of Cognitive Remediation for Schizophrenia: Efficacy and the Role of Participant and Treatment Factors.

Authors:  Julia A Lejeune; Andrew Northrop; Matthew M Kurtz
Journal:  Schizophr Bull       Date:  2021-07-08       Impact factor: 9.306

6.  Eighth Kraepelin Symposium-Translation in Psychiatry and Psychotherapy: A Life-Long Necessity.

Authors:  Schaub Annette; Falkai Peter
Journal:  Schizophr Bull       Date:  2021-04-29       Impact factor: 9.306

7.  Effects of Cognitive Remediation on Cognition, Metacognition, and Social Cognition in Patients With Schizophrenia.

Authors:  Cristiana Montemagni; Elisa Del Favero; Cecilia Riccardi; Laura Canta; Mario Toye; Enrico Zanalda; Paola Rocca
Journal:  Front Psychiatry       Date:  2021-07-09       Impact factor: 4.157

8.  Evidence-Based Integrated Intervention in Patients with Schizophrenia: A Pilot Study of Feasibility and Effectiveness in a Real-World Rehabilitation Setting.

Authors:  Gabriele Nibbio; Stefano Barlati; Paolo Cacciani; Paola Corsini; Alessandra Mosca; Anna Ceraso; Giacomo Deste; Antonio Vita
Journal:  Int J Environ Res Public Health       Date:  2020-05-12       Impact factor: 3.390

9.  Non-Invasive Brain Stimulation Does Not Improve Working Memory in Schizophrenia: A Meta-Analysis of Randomised Controlled Trials.

Authors:  Nicole P Sloan; Linda K Byrne; Peter G Enticott; Jarrad A G Lum
Journal:  Neuropsychol Rev       Date:  2020-09-12       Impact factor: 7.444

10.  Cognitive subtypes in recent onset psychosis: distinct neurobiological fingerprints?

Authors:  Nikolaos Koutsouleris; Lana Kambeitz-Ilankovic; Julian Wenzel; Shalaila S Haas; Dominic B Dwyer; Anne Ruef; Oemer Faruk Oeztuerk; Linda A Antonucci; Sebastian von Saldern; Carolina Bonivento; Marco Garzitto; Adele Ferro; Marco Paolini; Janusch Blautzik; Stefan Borgwardt; Paolo Brambilla; Eva Meisenzahl; Raimo K R Salokangas; Rachel Upthegrove; Stephen J Wood; Joseph Kambeitz
Journal:  Neuropsychopharmacology       Date:  2021-03-15       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.